https://www.kff.org/mental-health/tracking-key-mental-health-and-substance-use-policy-actions-under-the-trump-administration/KFFen2026-06-12T20:37:56+00:00Tracking Key Mental Health and Substance Use Policy Actions Under the Trump AdministrationAccess to Care, Opioids, Gun Violence, Substance Usehttps://www.kff.org/wp-content/uploads/sites/7/2025/08/251212_Tracker_Key-Mental-Health-and-Substance-Use-Federal-Policy-Actions_FI.png?w=150&h=150&crop=1https://www.kff.org/global-health-policy/u-s-foreign-aid-freeze-dissolution-of-usaid-timeline-of-events/KFFen2026-06-11T17:43:13+00:00U.S. Foreign Aid Freeze & Dissolution of USAID: Timeline of EventsMalaria, PEPFAR, Global Health Aid Cutshttps://www.kff.org/wp-content/uploads/sites/7/2025/03/Feature-Image-U.S.-Foreign-Aid-Freeze-Dissolution-of-USAID.png?w=150&h=150&crop=1https://www.kff.org/global-health-policy/overview-of-president-trumps-executive-actions-on-global-health/KFFen2026-06-11T17:43:08+00:00Overview of President Trump’s Executive Actions on Global HealthInternational Cooperation, PEPFAR, U.S. Government Programs, Gender Identity, Global Health Aid Cutshttps://www.kff.org/wp-content/uploads/sites/7/2025/01/Feature-Image-Overview-of-President-Trumps-Executive-Actions-on-Global-Health.png?w=150&h=150&crop=1https://www.kff.org/medicare/medicare-part-d-enrollment-premiums-and-cost-sharing-in-2026/KFFen2026-06-11T14:00:00+00:00Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026Benefits, Cost Sharing, Enrollment, Medicare Advantage, Medicare Part D, Premiums, Prescription Drugs, Traditional Medicarehttps://www.kff.org/wp-content/uploads/sites/7/2026/06/medicare-part-d-enrollment-in-stand-alone-prescription-drug-plans-increased-in-2026-but-enrollment-remains-higher-in-medicare-advantage-drug-plans_FI.png?w=150&h=150&crop=1https://www.kff.org/medicare/how-medicare-advantage-rebates-disadvantage-medicares-stand-alone-drug-plan-market/KFFen2026-06-11T14:00:00+00:00How Medicare Advantage Rebates Disadvantage Medicare’s Stand-Alone Drug Plan MarketMedicare Advantage, Medicare Part D, Premiums, Prescription Drugs, Medicare's Future, Seniors, Traditional Medicarehttps://www.kff.org/wp-content/uploads/sites/7/2026/06/How-Medicare-Advantage-Rebates-Disadvantage-Medicare-Stand-Alone-Drug-Plan-Market_FI.png?w=150&h=150&crop=1https://www.kff.org/affordable-care-act/tracking-insurer-participation-changes-in-the-aca-marketplaces-in-2027/KFFen2026-06-11T13:23:02+00:00Tracking Insurer Participation Changes in the ACA Marketplaces in 2027Coverage, ACA Marketplaces, Individual Market, Health Care Marketshttps://www.kff.org/wp-content/uploads/sites/7/2026/06/260610_Tracking-Insurer-Exits-and-Entrances-in-ACA-Marketplaces_Social.png?w=150&h=150&crop=1https://www.kff.org/affordable-care-act/how-has-insurer-participation-in-the-aca-marketplaces-changed-in-2026/KFFen2026-06-11T13:22:24+00:00How Has Insurer Participation in the ACA Marketplaces Changed in 2026?County-Level Data, Coverage, ACA Marketplaces, Individual Markethttps://www.kff.org/wp-content/uploads/sites/7/2026/06/ACA-Small-Business-Premiums-for-2026_9.24.25-FI.png?w=150&h=150&crop=1https://www.kff.org/health-information-trust/rare-or-unverified-outcomes-shape-vaccine-safety-and-gender-care-debates/KFFen2026-06-11T12:00:00+00:00Rare or Unverified Outcomes Shape Vaccine Safety and Gender Care Debates — The MonitorPublic Health, Sexually Transmitted Infections (STIs), Texas, Gender Identity, Vaccines, Food and Drug Administration (FDA), Measles, Artificial Intelligencehttps://www.kff.org/wp-content/uploads/sites/7/2026/06/260611_TheMonitor_FI.png?w=150&h=150&crop=1